Regulus Therapeutics (RGLS) Sees Early Gains

November 23, 2016 9:56 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Regulus Therapeutics (NASDAQ: RGLS) is seeing early gains on volume despite overall weakness in the biotech sector. RGLS is up 7.8% on volume that is running 5x the norm.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment